World's Best Scientists 2026 revealed!

D-Index & Metrics

Economics and Finance

D-Index
39
Citations
6387
World Ranking
2429
National Ranking
285

Adrian Towse publication distribution in Economics and Finance in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Economics and Finance in 2026. The highlighted bar marks where Adrian Towse sits on this spectrum.

42–46 publications: 1 scientists 47–51 publications: 12 scientists 52–56 publications: 7 scientists 57–61 publications: 23 scientists 62–66 publications: 32 scientists 67–71 publications: 36 scientists 72–76 publications: 56 scientists 77–81 publications: 57 scientists 82–86 publications: 70 scientists 87–91 publications: 86 scientists 92–96 publications: 72 scientists 97–101 publications: 106 scientists 102–106 publications: 97 scientists 107–111 publications: 96 scientists 112–116 publications: 101 scientists 117–121 publications: 103 scientists 122–126 publications: 102 scientists 127–131 publications: 108 scientists 132–136 publications: 107 scientists 137–141 publications: 111 scientists 142–146 publications: 94 scientists 147–151 publications: 96 scientists 152–156 publications: 100 scientists 157–161 publications: 74 scientists 162–166 publications: 68 scientists 167–171 publications: 91 scientists 172–176 publications: 76 scientists 177–181 publications: 75 scientists 182–186 publications: 61 scientists 187–191 publications: 66 scientists 192–196 publications: 68 scientists 197–201 publications: 71 scientists 202–206 publications: 60 scientists 207–211 publications: 56 scientists 212–216 publications: 44 scientists 217–221 publications: 51 scientists 222–226 publications: 65 scientists 227–231 publications: 48 scientists 232–236 publications: 59 scientists 237–241 publications: 37 scientists 242–246 publications: 37 scientists 247–251 publications: 41 scientists 252–256 publications: 43 scientists 257–261 publications: 33 scientists 262–266 publications: 34 scientists 267–271 publications: 39 scientists 272–276 publications: 25 scientists 277–281 publications: 29 scientists 282–286 publications: 29 scientists 287–291 publications: 26 scientists 292–296 publications: 31 scientists 297–301 publications: 31 scientists 302–306 publications: 24 scientists 307–311 publications: 28 scientists 312–316 publications: 24 scientists 317–321 publications: 13 scientists 322–326 publications: 14 scientists 327–331 publications: 25 scientists 332–336 publications: 18 scientists 337–341 publications: 16 scientists 342–346 publications: 18 scientists 347–351 publications: 15 scientists 352–356 publications: 17 scientists 357–361 publications: 19 scientists 362–366 publications: 16 scientists 367–371 publications: 17 scientists 372–376 publications: 7 scientists 377–381 publications: 18 scientists 382–386 publications: 13 scientists 387–391 publications: 19 scientists 392–396 publications: 9 scientists 397–401 publications: 10 scientists 402–406 publications: 13 scientists 407–411 publications: 13 scientists 412–416 publications: 5 scientists 417–421 publications: 10 scientists 422–426 publications: 6 scientists 427–431 publications: 12 scientists 432–436 publications: 9 scientists 437–441 publications: 9 scientists 442–446 publications: 10 scientists 447–451 publications: 12 scientists 452–456 publications: 8 scientists 457–461 publications: 4 scientists 462–466 publications: 7 scientists 467–471 publications: 4 scientists 472–476 publications: 5 scientists 477–481 publications: 6 scientists 482–486 publications: 7 scientists 487–491 publications: 8 scientists 492–496 publications: 5 scientists 497–501 publications: 4 scientists 502–506 publications: 4 scientists 507–511 publications: 5 scientists 512–516 publications: 7 scientists 517–520 publications: 7 scientists 521+ publications: 99 scientists
42 publications 521+

This scientist: 223 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 521 publications or more.

Adrian Towse D-index placement in Economics and Finance in 2026

The chart shows the D-index (discipline H-index) distribution of Economics and Finance scientists ranked by Research.com in 2026. The highlighted bar marks where Adrian Towse sits on this spectrum.

30 D-Index: 126 scientists 31 D-Index: 147 scientists 32 D-Index: 157 scientists 33 D-Index: 178 scientists 34 D-Index: 171 scientists 35 D-Index: 141 scientists 36 D-Index: 132 scientists 37 D-Index: 129 scientists 38 D-Index: 130 scientists 39 D-Index: 120 scientists 40 D-Index: 117 scientists 41 D-Index: 113 scientists 42 D-Index: 114 scientists 43 D-Index: 97 scientists 44 D-Index: 115 scientists 45 D-Index: 86 scientists 46 D-Index: 78 scientists 47 D-Index: 83 scientists 48 D-Index: 62 scientists 49 D-Index: 74 scientists 50 D-Index: 50 scientists 51 D-Index: 66 scientists 52 D-Index: 69 scientists 53 D-Index: 55 scientists 54 D-Index: 67 scientists 55 D-Index: 61 scientists 56 D-Index: 62 scientists 57 D-Index: 45 scientists 58 D-Index: 34 scientists 59 D-Index: 47 scientists 60 D-Index: 46 scientists 61 D-Index: 36 scientists 62 D-Index: 37 scientists 63 D-Index: 56 scientists 64 D-Index: 50 scientists 65 D-Index: 32 scientists 66 D-Index: 28 scientists 67 D-Index: 30 scientists 68 D-Index: 24 scientists 69 D-Index: 25 scientists 70 D-Index: 22 scientists 71 D-Index: 21 scientists 72 D-Index: 26 scientists 73 D-Index: 24 scientists 74 D-Index: 23 scientists 75 D-Index: 12 scientists 76 D-Index: 14 scientists 77 D-Index: 15 scientists 78 D-Index: 15 scientists 79 D-Index: 17 scientists 80 D-Index: 17 scientists 81 D-Index: 11 scientists 82 D-Index: 10 scientists 83 D-Index: 16 scientists 84 D-Index: 11 scientists 85 D-Index: 5 scientists 86 D-Index: 9 scientists 87 D-Index: 13 scientists 88 D-Index: 9 scientists 89 D-Index: 7 scientists 90 D-Index: 6 scientists 91 D-Index: 4 scientists 92 D-Index: 8 scientists 93 D-Index: 10 scientists 94 D-Index: 11 scientists 95 D-Index: 6 scientists 96 D-Index: 4 scientists 97 D-Index: 4 scientists 98 D-Index: 6 scientists 99 D-Index: 6 scientists 100 D-Index: 8 scientists 101+ D-Index: 100 scientists
30 D-Index 101+

This scientist: 39 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 101 D-Index or more.

Overview

Adrian Towse is affiliated with the Office of Health Economics in the United Kingdom. Their research primarily spans the field of Economics, Econometrics and Finance, with a focus on Economics and Econometrics. Towse's work also incorporates elements of General Health Professions, Public Health, Environmental and Occupational Health, Health, and Pharmacology.

The scientist's research extensively covers topics related to Health Systems, Economic Evaluations, and Quality of Life. Their work also addresses Pharmaceutical Economics and Policy, Healthcare Policy and Management, Healthcare cost, quality, and practices, Global Health Care Issues, Vaccine Coverage and Hesitancy, as well as the Economic and Financial Impacts of Cancer.

Towse has published in several prominent venues, including:

  • Value in Health
  • Cost Effectiveness and Resource Allocation
  • Frontiers in Health Services
  • Vaccine
  • BMC Health Services Research

Notable recent papers by Towse include:

  • Establishing a reasonable price for an orphan drug (2020, Cost Effectiveness and Resource Allocation)
  • Considering Severity in Health Technology Assessment: Can We Do Better? (2022, Value in Health)
  • Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop (2021, BMC Health Services Research)
  • Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy (2022, Applied Health Economics and Health Policy)
  • Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment-Rationale and Empirical Support (2020, Journal of Managed Care & Specialty Pharmacy)

Frequent collaborators in Towse's work include:

  • Mikel Berdud
  • Bernarda Zamora
  • Lotte Steuten
  • Michael Drummond
  • Andrew W. Bruce

Their research is characterized by an emphasis on economic evaluations within health care systems and a focus on cost-effectiveness analyses related to pharmaceuticals and broader health policy. Their contributions also address important issues such as pricing in orphan drugs and the assessment of severity in health technology evaluations.

Best Publications

  • Differential pricing for pharmaceuticals: reconciling access, R&D and patents.

    Patricia M. Danzon;Adrian Towse

  • Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.

    Louis P. Garrison;Adrian Towse;Andrew Briggs;Gerard de Pouvourville

  • Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.

    Marc L. Berger;Nancy Dreyer;Fred Anderson;Adrian Towse

  • Learning from Thailand's health reforms

    Adrian Towse;Anne Mills;Viroj Tangcharoensathien

  • Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement

    Patricia M. Danzon;Andrew W. Mulcahy;Adrian K. Towse

  • The R&D Cost of a New Medicine

    J. Mestre-Ferrandiz;J. Sussex;Adrian Towse

  • Value-based differential pricing: efficient prices for drugs in a global context.

    Patricia M Danzon;Adrian K Towse;Jorge Mestre-Ferrandiz

  • Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.

    Eric Faulkner;Lieven Annemans;Lou Garrison;Mark Helfand

  • A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

    Louis P. Garrison;Peter J. Neumann;Richard J. Willke;Anirban Basu

  • Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products.

    Adrian Towse;Louis P. Garrison

  • Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.

    Marco Barbieri;Michael Drummond;Richard Willke;Jeremy Chancellor

  • Using QALYs in cancer: a review of the methodological limitations.

    Martina Garau;Koonal K. Shah;Anne R. Mason;Qing Wang

  • Should NICE's threshold range for cost per QALY be raised? Yes.

    Adrian Towse

  • Cost-effectiveness Thresholds: Economic and Ethical Issues

    A. Towse;C. Pritchard;N. eds Devlin

  • Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis

    Louis P. Garrison;Sachin Kamal-Bahl;Adrian Towse

  • Operationalizing value-based pricing of medicines : a taxonomy of approaches.

    Jon Sussex;Adrian Towse;Nancy Devlin

  • Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare.

    Bengt Jönsson;Grace Hampson;Jonathan Michaels;Adrian Towse

  • Gene therapy: evidence, value and affordability in the US health care system

    Grace Hampson;Adrian Towse;Steven D Pearson;William B Dreitlein

  • The Economics of Gene Therapy and of Pharmacogenetics

    Patricia Danzon;Adrian Towse

  • Orphan drugs policies: a suitable case for treatment

    Michael Drummond;Adrian Towse

  • Assessing A Structured, Quantitative Health Outcomes Approach To Drug Risk-Benefit Analysis

    Louis P. Garrison;Adrian Towse;Brian W. Bresnahan

Frequent Co-Authors

Louis P. Garrison
Louis P. Garrison University of Washington
Michael Drummond
Michael Drummond University of York
Patricia M. Danzon
Patricia M. Danzon University of Pennsylvania
Nancy Devlin
Nancy Devlin University of Melbourne
Kalipso Chalkidou
Kalipso Chalkidou Center for Global Development
Alastair Gray
Alastair Gray University of Oxford
Darius N. Lakdawalla
Darius N. Lakdawalla University of Southern California
David Parkin
David Parkin City, University of London
Peter J. Neumann
Peter J. Neumann University of Bern
Bengt Jönsson
Bengt Jönsson Stockholm School of Economics

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Advancing your education in Economics and Finance opens doors to diverse online degrees that complement and expand your expertise. Many students pursue a data analytics master's degree online, building critical skills in interpreting and leveraging financial data—highly valued by employers in today’s data-driven environment.

For those aiming to lead teams and drive organizational change, an online master's degree in organizational leadership can be a strategic next step. This degree strengthens your management capabilities, preparing you for leadership roles within financial institutions or corporate settings.

Another in-demand option is a business intelligence masters, which focuses on utilizing advanced analytical methods to improve business decision-making. This pathway is ideal for those interested in harnessing technology to uncover trends and strategies within financial markets.

If you’re seeking broad business acumen with added flexibility, consider a flexible mba no gmat. These programs allow you to earn a prestigious MBA without entrance exam barriers, paving the way for senior management roles in the finance sector.

Best Scientists Citing Adrian Towse

Trending Scientists

Recently Published Articles